Proton beams control liver tumors

	Tweet

Patients with liver tumors called hepatocellular carcinomas and who have few other treatment options are likely to benefit from proton beam radiation therapy, Japanese researchers report in the journal Cancer.

Lead investigator Dr. Masaharu Hata told Reuters Health: “Proton beam therapy was given safely and effectively to a wide spectrum of patients with hepatocellular carcinoma.”

Hata and colleagues at the University of Tsukuba took a look back at 21 patients with liver tumors for whom other treatment modalities were contraindicated or not feasible because of coexisting diseases such as severe Cirrhosis, kidney failure, and severe heart disease.

Seven of the patients had multiple liver tumors. The median tumor diameter was 40 mm. No patients had regional or distant metastases.

At a median of 3.3 years after proton beam radiation, all but one of the tumors was controlled. At 5 years, the objective response rate was 81 percent and the primary site control rate was 93 percent.

Four of 11 patients who developed recurrent liver tumors had a second course of proton beam therapy, which controlled the tumors.

At 5 years, overall survival was 33 percent and cause-specific survival was 67 percent.

Proton beam therapy was well tolerated.

“The results suggested that this method was tolerable and effective,” concluded Hata, “even for patients who had severe coexisting diseases or unfavorable conditions for whom other treatment modalities were contraindicated or unfeasible.”

Cancer August 2006.

RELATED STORIES:
Saffron shows promise in preventing liver cancer   Hepatitis C ups liver cancer risk, study confirms   Personalized treatment may help some liver cancer patients   Liver Tumors Associated with Metabolic Syndrome Differ from Other Tumors   Omega-3 fatty acids inhibit the growth of liver cancer cells   Metformin May Protect Against Liver Cancer   Mayo Clinic Studies Identify Risk Factors in Rising Trend of Liver Cancer   Eating mandarins reduces the risk of liver disease, hardened arteries and insulin resistance   Statins may cut liver cancer risk in diabetics   Racial disparities evident in early-stage liver cancer survival   A diagnostic marker in hepatocellular carcinoma   Researchers Identify Gene Linked to Aggressive Progression of Liver Cancer   The ignored virus that causes liver cancer   Combination Therapy Improves Survival Time For Patients With Advanced Liver Cancer   More evidence coffee may cut risk of liver cancer   Blacks with Liver Cancer More Likely to Die   How to differentiate benign from malignant bile duct strictures?   Statins may cut liver cancer risk for diabetics   Liver cancer incidence lower in patients with nonalcoholic fatty liver disease than hepatitis C   Researchers find gene to fight liver cancer   Cycles of Cell Death, Proliferation Key to Liver Cancer   Studies of patients with cirrhosis uncover limitations in liver cancer screening

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]